Invokana 300 mg film-coated tablets

DRUG3 trials

Sponsors

Center For Outcomes Research And Clinical Epidemiology S.r.l., Universitair Medisch Centrum Groningen, Humanitas Mirasole S.p.A.

Conditions

Chronic Kidney diseaseMyocardial InfarctionType 2 diabetes mellitusdiabetes mellitus

Phase 3

Sodium-glucose cotransporter-2 inhibitors to stABiLizE coronary atherosclerosis pro-gression after acute Myocardial Infarction in women and men with diabetes mellitus

Not yet recruitingCTIS2025-523375-29-00

Humanitas Mirasole S.p.A.diabetes mellitus, Myocardial Infarction

Target: 300Updated: 2026-02-06

Phase 4

Intraclass safety and efficacy comparison among SGLT-2 inhibitors in elderly patients with type 2 diabetes. A pragmatic, phase IV, multicenter, open-label, randomised controlled trial.

CompletedCTIS2024-518915-20-00

Center For Outcomes Research And Clinical Epidemiology S.r.l.Type 2 diabetes mellitus

Start: 2022-02-16End: 2025-10-02Target: 1167Updated: 2025-09-30

CANIDIAP; CANagliflozin In DIAlysis Patients

Not yet recruitingCTIS2025-522742-46-00

Universitair Medisch Centrum GroningenChronic Kidney disease

Target: 10Updated: 2026-02-23